Pretreatment with an angiotensin II receptor blocker abolished ameliorating actions of adipose-derived stem cell sheets on cardiac dysfunction and remodeling after myocardial infarction
Keywords: آنژیوتانسین دو; Adipose-derived stem cell sheet; Myocardial infarction; Angiotensin II; Irbesartan; VEGF; ANP; atrial natriuretic peptide; ARB; angiotensin receptor blocker; ASC; adipose-derived stem cell; AT1(2)R; angiotensin II receptor type 1(2); CRT; cardiac resynchr